Cargando…
An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice
INTRODUCTION: Integrin α6 is an attractive diagnostic biomarker for molecular imaging of hepatocellular carcinoma (HCC) as it has an extremely high positive rate (approximately 94%) in clinical early-stage HCC. In this study, based on our previously identified integrin α6-targeted peptide, we develo...
Autores principales: | Lin, Bing-Quan, Zhang, Wen-Biao, Zhao, Jing, Zhou, Xu-Hui, Li, Yong-Jiang, Deng, Jun, Zhao, Qin, Fu, Gui, Xie, Chuan-Miao, Xu, Yi-Kai, Feng, Guo-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244641/ https://www.ncbi.nlm.nih.gov/pubmed/34235103 http://dx.doi.org/10.2147/JHC.S312921 |
Ejemplares similares
-
A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes
por: Liu, Yajie, et al.
Publicado: (2013) -
An optimized integrin α6‐targeted peptide for positron emission tomography/magnetic resonance imaging of pancreatic cancer and its precancerous lesion
por: Mei, Yan, et al.
Publicado: (2020) -
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
por: Zhao, Menglong, et al.
Publicado: (2018) -
Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment
por: Zhao, Dongxu, et al.
Publicado: (2022) -
Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
por: Ma, Xiao-Hong, et al.
Publicado: (2019)